Rain Oncology OverviewRain Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for RAIN.
Quarterly EBIT
-$1.93M
↓ 43.14% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$8.31M
↓ 49.78% YoY
Trailing 12 months ending Mar 31, 2026
Rain Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for RAIN.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026